Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 0 | 0 | 0 | 13 | 0 |
| Gross Profit | 0 | 0 | 0 | 10 | 0 |
| Operating Expenses | 8,170 | 6,620 | 5,800 | 7,230 | 7,190 |
| Operating Income | -8,170 | -6,620 | -5,800 | -7,217 | -7,190 |
| Other Income | 210 | 50 | 3,980 | 117 | 150 |
| Pre-tax Income | -7,960 | -6,570 | -1,820 | -7,100 | -7,040 |
| Net Income Continuous | -5,273 | -5,552 | -1,800 | -7,108 | -7,048 |
| Net Income | $-5,273 | $-5,552 | $-1,800 | $-7,108 | $-7,048 |
| EPS Basic Total Ops | -26.41 | -28.81 | -12.01 | -60.02 | -60.02 |
| EPS Basic Continuous Ops | -27.51 | -28.98 | -11.53 | -59.23 | -59.88 |
| EPS Diluted Total Ops | -26.41 | -28.81 | -12.01 | -60.02 | -60.02 |
| EPS Diluted Continuous Ops | -27.51 | -28.98 | -11.53 | -59.23 | -59.88 |
| EBITDA(a) | $-8,160 | $-6,570 | $-5,740 | $-7,157 | $-7,130 |